Bristol Myers Squibb CoUSD 2.00 Cum.Conv News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

21.11.24	Is Bristol Myers Squibb Stock a Buy? (MotleyFool)
12.11.24	This Bristol-Myers Squibb Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday (Benzinga)
11.11.24	What's Going On With Bristol-Myers Squibb Shares Monday? (Benzinga)
08.11.24	Bristol-Myers Squibb Leads Biopharma Recovery With Almost 25% Growth In Market Cap, But Novo Nordisk And Lilly Suffer Market Setbacks (Benzinga)
01.11.24	Bristol Myers Squibb Expects New Schizophrenia Treatment To Boost Long-Term Growth, Analysts Remain Cautious (Benzinga)
31.10.24	Bristol Myers Squibb (BMY) Q3 2024 Earnings Call Transcript (MotleyFool)
31.10.24	Bristol Myers Squibb Boosts 2024 Outlook On Strong Demand For Blood Thinner Med, New Drugs Drive Q3 Profit (Benzinga)
23.10.24	Unpacking the Latest Options Trading Trends in Bristol-Myers Squibb (Benzinga)
07.10.24	Unveiling 11 Analyst Insights On Bristol-Myers Squibb (Benzinga)
01.10.24	This Is What Whales Are Betting On Bristol-Myers Squibb (Benzinga)
30.09.24	Prime Medicine Inks Cell Therapy Pact With Bristol Myers Squibb Worth Over $3.5B, Streamlines Pipeline (Benzinga)
27.09.24	Bristol-Myers Squibb stock jumps on schizophrenia drug approval (MarketWatch)
18.09.24	Bristol Myers Squibb Presents Data For Multiple Sclerosis Drug Zeposia, Shows Long-Term Efficacy (Benzinga)
16.09.24	What Analysts Are Saying About Bristol-Myers Squibb Stock (Benzinga)
02.09.24	2 Reasons Bristol Myers Squibb Stock Could Be a Bargain, Down 34% From Its All-Time High (MotleyFool)
22.08.24	Key Takeaways From Bristol-Myers Squibb Analyst Ratings (Benzinga)
18.08.24	Where Will Bristol Myers Squibb Be in 5 Years? (MotleyFool)
16.08.24	Jim Cramer empfiehlt: Diese Dividenden-Aktien bieten starkes Potenzial (finanzen.ch) Die starke Marktrally im ersten Halbjahr wurde vor allem von den KI-Gewinner-Aktien getrieben. Dividendenstarke Papiere standen in der Gunst der Anleger hingegen nicht allzu hoch - das könnte sich nun aber ändern.» mehr
05.08.24	Bristol Myers Squibb Terminates Cancer Drug Development Program With Agenus (Benzinga)
30.07.24	Is Bristol Myers Squibb a Good Dividend Stock to Buy Now? (MotleyFool)
29.07.24	This Bristol-Myers Squibb Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday (Benzinga)
26.07.24	Why Bristol Myers Squibb Jumped Nearly 10% on Friday (MotleyFool)
26.07.24	Bristol Myers Squibb (BMY) Q2 2024 Earnings Call Transcript (MotleyFool)
26.07.24	Bristol Myers Squibb Raises Outlook After Solid Q2 Earnings (MotleyFool)
26.07.24	Bristol Myers Squibb Witnesses Strong Demand For 'Newer Drugs' As Q2 Earnings Beat Expectations, Raises 2024 Profit Forecast (Benzinga)
26.07.24	Bristol Myers Squibb results beat expectations as newer drugs deliver growth (MarketWatch)
26.07.24	Bristol-Myers Squibb, Deckers Outdoor And 3 Stocks To Watch Heading Into Friday (Benzinga)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Bristol Myers Squibb CoUSD 2.00 Cum.Conv.Pfd Shs

Aktien Top/Flop

Meistgelesene Nachrichten